Table 2 Relationship between chemotherapy use and patient characteristics: univariate (Table 2a) and multi-variable (Table 2b) analyses.

From: Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer

(a) Results for univariate logistic regression models.

Variable

Level

OR (95% CI)

P-value

Age

 

0.84 (0.82, 0.87)

<0.001

ADL score

 

1.07 (1.04, 1.11)

<0.001

IADL score

 

1.77 (1.43, 2.25)

<0.001

CCI (no age)

 

0.84 (0.77, 0.93)

<0.001

APG-SGA

 

0.95 (0.89, 1.01)

0.127

Allred score

 

0.80 (0.78, 0.83)

<0.001

Tumour grade

Grade 1

 

Grade 2

9.04 (3.78, 29.58)

<0.001

 

Grade 3

37.67 (15.87, 122.76)

<0.001

ER positive

 

0.22 (0.17, 0.28)

<0.001

HER2 statusa

Negative

 

Positive

8.49 (6.57, 10.97)

<0.001

MMSE category

Normal function

 

Mild impairment

0.75 (0.49, 1.11)

0.172

 

Moderate impairment

1.18 (0.44, 2.67)

0.711

 

Severe

0.38 (0.06, 1.27)

0.188

Nodal statusb

pN0-1mi

 

pN1

2.18 (1.69, 2.80)

<0.001

 

pN2

5.05 (3.47, 7.29)

<0.001

 

pN3

6.42 (3.96, 10.30)

<0.001

(b) Results from the multi-variable logistic regression model.

Variable

Level

OR (95% CI)

P-value

Age

 

0.74 (0.71, 0.78)

<0.001

IADL score

 

1.97 (1.53, 2.63)

<0.001

CCI (no age)

 

0.83 (0.73, 0.95)

0.007

Tumour grade

Grade 1

 

Grade 2

8.42 (3.05, 34.90)

<0.001

 

Grade 3

29.50 (10.59, 123.00)

<0.001

ER positive

 

0.19 (0.13, 0.28)

<0.001

HER2 status

Negative

 

Positive

8.94 (6.19, 13.01)

<0.001

Nodal status

pN0-1mi

  
 

pN1

4.01 (2.81, 5.75)

<0.001

 

pN2

11.24 (6.43, 19.74)

<0.001

 

pN3

8.84 (4.31, 18.05)

<0.001

  1. aTests marked as ‘Inconclusive’ were removed from this analysis.
  2. bThose with nodal status pNx were removed from this analysis.